Thus, a liquid biopsy-guided approach at progression in elderly patients with reduced PS and reduced tolerability for tumor rebiopsies may offer feasible and effective therapy guidance, as in this case where it disclosed the option of combining ALK- and EGFR-TKI. This evidence concerns the gene EGFR and neoplasm.